Aqneursa Dosage
Generic name: LEVACETYLLEUCINE 1000mg
Dosage form: granule, for oral suspension
Drug class: Miscellaneous metabolic agents
Medically reviewed by Drugs.com. Last updated on Jan 23, 2025.
Important Recommendation Prior to AQNEURSA Treatment Initiation
For females of reproductive potential, verify that the patient is not pregnant.
Recommended Dosage
The recommended dosage of AQNEURSA is based on the patient’s actual body weight (kg) to be administered orally up to three times daily. See Table 1.
AQNEURSA can be taken with or without food.
For 2 gram levacetylleucine doses, prepare two AQNEURSA packets individually.
Patient’s Body Weight |
Morning Dose |
Afternoon Dose |
Evening Dose |
15 kg to less than 25 kg |
1 gram |
No Dose |
1 gram |
25 kg to less than 35 kg |
1 gram |
1 gram |
1 gram |
35 kg or more |
2 gram |
1 gram |
1 gram |
One AQNEURSA packet contains 1 gram levacetylleucine.
Missed Dose
If a dose of AQNEURSA is missed, skip the missed dose and take the next dose at the scheduled time. Do not take 2 doses at the same time to make up for a missed dose.
Preparation and Administration Instructions
Oral Administration
For oral administration, administer AQNEURSA as follows:
- 1. Obtain the required number of AQNEURSA packets for the prescribed dose (one or two packets).
- 2. Open and empty the entire contents of one AQNEURSA packet into a container with 40 mL of water, orange juice, or almond milk. Do not use hot liquid.
- 3. Stir to form a suspension.
- 4. Swallow the suspension immediately (within 30 minutes).
- 5. For doses requiring two AQNEURSA packets, repeat steps 2 to 4.
- 6. Discard unused AQNEURSA suspension if not administered within 30 minutes.
Use of Gastrostomy Tube (G-Tube) for Feeding Tube Administration
For patients who have a G-tube (French size 18 or larger) in place, administer AQNEURSA as follows:
- 1. Prepare AQNEURSA suspension immediately before administration via gastrostomy tube.
- 2. Obtain the required number of AQNEURSA packets for the prescribed dose (one or two packets).
- 3. Open and empty the entire contents of one AQNEURSA packet into a container with 40 mL of water ONLY. Do not use hot liquid.
- 4. Stir to form a suspension.
- 5. Draw up the suspension into a catheter tip syringe.
- 6. Administer the suspension immediately through the G-tube.
- 7. Flush any residual suspension in the catheter tip syringe with an additional 20 mL of water.
- 8. Flush the G-tube again, as needed, until no residual suspension is left in the syringe or feeding tube.
- 9. For doses requiring two AQNEURSA packets, repeat steps 3 to 8.
- 10. Discard unused AQNEURSA suspension if not administered immediately.
Frequently asked questions
More about Aqneursa (levacetylleucine)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- During pregnancy
- FDA approval history
- Drug class: miscellaneous metabolic agents
- En español
Patient resources
Professional resources
Related treatment guides
See also:
Miplyffa
Miplyffa (arimoclomol) is a medication for Niemann-Pick disease type C (NPC) to help stop disease ...
Amvuttra
Amvuttra is used to treat polyneuropathy associated with hereditary transthyretin-mediated ...
Cerdelga
Cerdelga (eliglustat) is used to treat mild to moderate Type 1 Gaucher Disease. Includes Cerdelga ...
Crysvita
Crysvita is used for familial hypophosphatemia, osteomalacia, X-Linked Hypophosphatemia
Galafold
Galafold (migalastat) is used to treat Fabry disease. Includes Galafold side effects, interactions ...
Givlaari
Givlaari injection is used for acute hepatic porphyria (AHP) to reduce the number of acute attacks ...
Iqirvo
Iqirvo (elafibranor) is used to treat primary biliary cholangitis (PBC) in combination with ...
Kuvan
Kuvan is used to help the body activate the enzyme needed to control blood levels of phenylalanine ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.